173 related articles for article (PubMed ID: 23731360)
1. Synthesis of mixed (E,Z)-, (E)-, and (Z)-norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities.
Lv W; Liu J; Lu D; Flockhart DA; Cushman M
J Med Chem; 2013 Jun; 56(11):4611-8. PubMed ID: 23731360
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.
Lv W; Liu J; Skaar TC; Flockhart DA; Cushman M
J Med Chem; 2015 Mar; 58(6):2623-48. PubMed ID: 25751283
[TBL] [Abstract][Full Text] [Related]
3. A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and β.
Zhao LM; Jin HS; Liu J; Skaar TC; Ipe J; Lv W; Flockhart DA; Cushman M
Bioorg Med Chem; 2016 Nov; 24(21):5400-5409. PubMed ID: 27647367
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cytochrome p450 enzymes by the e- and z-isomers of norendoxifen.
Liu J; Flockhart PJ; Lu D; Lv W; Lu WJ; Han X; Cushman M; Flockhart DA
Drug Metab Dispos; 2013 Sep; 41(9):1715-20. PubMed ID: 23824607
[TBL] [Abstract][Full Text] [Related]
5. The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents.
Lu WJ; Xu C; Pei Z; Mayhoub AS; Cushman M; Flockhart DA
Breast Cancer Res Treat; 2012 May; 133(1):99-109. PubMed ID: 21814747
[TBL] [Abstract][Full Text] [Related]
6. Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
Pigeon P; Top S; Vessières A; Huché M; Hillard EA; Salomon E; Jaouen G
J Med Chem; 2005 Apr; 48(8):2814-21. PubMed ID: 15828819
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors.
Lv W; Liu J; Skaar TC; O'Neill E; Yu G; Flockhart DA; Cushman M
J Med Chem; 2016 Jan; 59(1):157-70. PubMed ID: 26704594
[TBL] [Abstract][Full Text] [Related]
8. A convenient synthesis of (Z)-4-hydroxy-N-desmethyltamoxifen (endoxifen).
Fauq AH; Maharvi GM; Sinha D
Bioorg Med Chem Lett; 2010 May; 20(10):3036-8. PubMed ID: 20400308
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells.
Burke PJ; Koch TH
J Med Chem; 2004 Feb; 47(5):1193-206. PubMed ID: 14971899
[TBL] [Abstract][Full Text] [Related]
10. Influence of the length and positioning of the antiestrogenic side chain of endoxifen and 4-hydroxytamoxifen on gene activation and growth of estrogen receptor positive cancer cells.
Maximov PY; Fernandes DJ; McDaniel RE; Myers CB; Curpan RF; Jordan VC
J Med Chem; 2014 Jun; 57(11):4569-83. PubMed ID: 24805199
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of boroxifen, a nido-carborane analogue of tamoxifen.
Valliant JF; Schaffer P; Stephenson KA; Britten JF
J Org Chem; 2002 Jan; 67(2):383-7. PubMed ID: 11798307
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Receptor α (ERα)-targeting Compounds and Derivatives: Recent Advances in Structural Modification and Bioactivity.
Guo WY; Zeng SM; Deora GS; Li QS; Ruan BF
Curr Top Med Chem; 2019; 19(15):1318-1337. PubMed ID: 31215379
[TBL] [Abstract][Full Text] [Related]
13. Target specific virtual screening: optimization of an estrogen receptor screening platform.
Knox AJ; Meegan MJ; Sobolev V; Frost D; Zisterer DM; Williams DC; Lloyd DG
J Med Chem; 2007 Nov; 50(22):5301-10. PubMed ID: 17918820
[TBL] [Abstract][Full Text] [Related]
14. Construction of benzofuranone library via a metal-free, one-pot intermolecular condensation, and their application as efficient estrogen receptor β modulators.
Peng X; Hu Z; Zhang J; Ning W; Zhang S; Dong C; Shi X; Zhou HB
Chem Commun (Camb); 2019 Dec; 55(97):14570-14573. PubMed ID: 31660550
[TBL] [Abstract][Full Text] [Related]
15. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Halleux C; Kallen J; Keller H; Schlaeppi JM; Stark W
J Med Chem; 2003 Jul; 46(14):2945-57. PubMed ID: 12825935
[TBL] [Abstract][Full Text] [Related]
17. Novel aromatase inhibitors by structure-guided design.
Ghosh D; Lo J; Morton D; Valette D; Xi J; Griswold J; Hubbell S; Egbuta C; Jiang W; An J; Davies HM
J Med Chem; 2012 Oct; 55(19):8464-76. PubMed ID: 22951074
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.
Jordan VC
J Med Chem; 2003 Mar; 46(7):1081-111. PubMed ID: 12646017
[No Abstract] [Full Text] [Related]
19. Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer.
Lu WJ; Desta Z; Flockhart DA
Breast Cancer Res Treat; 2012 Jan; 131(2):473-81. PubMed ID: 21390495
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
